Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Revolution Healthcare Acquisition EBITDA Margin % Related Terms
Revolution Healthcare Acquisition EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
REVHW vs TSPQ, GTPB, VAQC: EBITDA Margin % Comparison
For the Shell Companies subindustry, Revolution Healthcare Acquisition's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revolution Healthcare Acquisition EBITDA Margin % vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Revolution Healthcare Acquisition's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Revolution Healthcare Acquisition's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revolution Healthcare Acquisition (REVHW) has a EBITDA Margin % of 0.00% as of Sep. 2022. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Revolution Healthcare Acquisition and its competitors.
Is Revolution Healthcare Acquisition's EBITDA Margin % too high?
Revolution Healthcare Acquisition's current EBITDA Margin % is 0.00%. Overall, Revolution Healthcare Acquisition has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Revolution Healthcare Acquisition's EBITDA Margin % compare to TSPQ and GTPB?
Revolution Healthcare Acquisition's EBITDA Margin % of 0.00% can be compared against companies in the Diversified Financial Services industry. The industry median EBITDA Margin % is 12.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Diversified Financial Services company?
The median EBITDA Margin % among Diversified Financial Services companies is 12.55, based on 83 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Revolution Healthcare Acquisition and its competitors. For the Diversified Financial Services industry, the median EBITDA Margin % is 12.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revolution Healthcare Acquisition's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revolution Healthcare Acquisition stock overvalued right now?
Revolution Healthcare Acquisition (REVHW) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Revolution Healthcare Acquisition's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Revolution Healthcare Acquisition (REVHW), the current EBITDA Margin % is 0.00% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
REVHW has been successfully added to your 
